2023
Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era
Carpiano R, Callaghan T, DiResta R, Brewer N, Clinton C, Galvani A, Lakshmanan R, Parmet W, Omer S, Buttenheim A, Benjamin R, Caplan A, Elharake J, Flowers L, Maldonado Y, Mello M, Opel D, Salmon D, Schwartz J, Sharfstein J, Hotez P. Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era. The Lancet 2023, 401: 967-970. PMID: 36871571, PMCID: PMC9981160, DOI: 10.1016/s0140-6736(23)00136-8.Peer-Reviewed Original Research
2022
The legacy of the COVID-19 pandemic for childhood vaccination in the USA
Opel DJ, Brewer NT, Buttenheim AM, Callaghan T, Carpiano RM, Clinton C, Elharake JA, Flowers LC, Galvani AP, Hotez PJ, Schwartz JL, Benjamin RM, Caplan A, DiResta R, Lakshmanan R, Maldonado YA, Mello MM, Parmet WE, Salmon DA, Sharfstein JM, Omer SB. The legacy of the COVID-19 pandemic for childhood vaccination in the USA. The Lancet 2022, 401: 75-78. PMID: 36309017, PMCID: PMC9605265, DOI: 10.1016/s0140-6736(22)01693-2.Peer-Reviewed Original Research
2021
Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA
Omer SB, Benjamin RM, Brewer NT, Buttenheim AM, Callaghan T, Caplan A, Carpiano RM, Clinton C, DiResta R, Elharake JA, Flowers LC, Galvani AP, Lakshmanan R, Maldonado YA, McFadden SM, Mello MM, Opel DJ, Reiss DR, Salmon DA, Schwartz JL, Sharfstein JM, Hotez PJ. Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA. The Lancet 2021, 398: 2186-2192. PMID: 34793741, PMCID: PMC8592561, DOI: 10.1016/s0140-6736(21)02507-1.Peer-Reviewed Original ResearchConceptsCOVID-19 vaccineSARS-CoV-2 infectionCOVID-19 vaccination campaignCOVID-19 vaccine acceptanceCOVID-19 vaccine programPfizer-BioNTech vaccineEmergency use authorisationVaccine programVaccine acceptanceVaccination campaignVaccine refusalCommunity transmissionUS FoodDrug AdministrationInadequate uptakeVaccineBehavioral intervention strategiesBest interventionLancet CommissionLow uptakeIntervention strategiesCOVID-19Evidence-based educationFull approvalUS residentsCOVID-19 Vaccination of Minors Without Parental Consent
Morgan L, Schwartz JL, Sisti DA. COVID-19 Vaccination of Minors Without Parental Consent. JAMA Pediatrics 2021, 175: 995-996. PMID: 34251411, DOI: 10.1001/jamapediatrics.2021.1855.Peer-Reviewed Original ResearchAssessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021
Paltiel AD, Schwartz JL. Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021. Annals Of Internal Medicine 2021, 174: m21-2965. PMID: 34461034, PMCID: PMC8422997, DOI: 10.7326/m21-2965.Peer-Reviewed Original ResearchConceptsVaccine effectivenessVaccination coverageAsymptomatic testingBroad vaccination coverageLess frequent testingCOVID-19 prevention strategiesHigh vaccination ratesBase-case assumptionsFall 2021COVID-19 incidenceUnvaccinated personsVaccination ratesDisease progressionHypothetical cohortEffective vaccineAsymptomatic transmissionPrevention strategiesViral transmissionCumulative casesNonpharmaceutical interventionsDrug abuseCumulative infectionsSafe returnVaccinePopulation coverageCharacteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration
Egilman A, Wallach JD, Puthumana J, Zhang AD, Schwartz JL, Ross JS. Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration. Journal Of General Internal Medicine 2021, 36: 3281-3284. PMID: 34131876, PMCID: PMC8205312, DOI: 10.1007/s11606-021-06943-x.Peer-Reviewed Original ResearchSpeed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration
Puthumana J, Egilman AC, Zhang AD, Schwartz JL, Ross JS. Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration. JAMA Internal Medicine 2021, 181: 559-560. PMID: 33170923, PMCID: PMC7656319, DOI: 10.1001/jamainternmed.2020.7472.Peer-Reviewed Original ResearchDemographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010–2020
Zhang AD, Puthumana J, Egilman AC, Schwartz JL, Ross JS. Demographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010–2020. Journal Of General Internal Medicine 2021, 37: 700-702. PMID: 33660209, PMCID: PMC7928194, DOI: 10.1007/s11606-021-06670-3.Peer-Reviewed Original ResearchMeSH KeywordsDemographyDrug ApprovalHumansUnited StatesUnited States Food and Drug AdministrationVaccinesAnnouncing the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA
Commissioners of the Lancet Commission on Vaccine Refusal A, Hotez P, Cooney R, Benjamin R, Brewer N, Buttenheim A, Callaghan T, Caplan A, Carpiano R, Clinton C, DiResta R, Elharake J, Flowers L, Galvani A, Lakshmanan R, Maldonado Y, McFadden S, Mello M, Opel D, Reiss D, Salmon D, Schwartz J, Sharfstein J, Omer S. Announcing the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA. The Lancet 2021, 397: 1165-1167. PMID: 33639088, DOI: 10.1016/s0140-6736(21)00372-x.Peer-Reviewed Original ResearchSpeed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment
Paltiel AD, Zheng A, Schwartz JL. Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment. Annals Of Internal Medicine 2021, 174: m20-7866. PMID: 33395345, PMCID: PMC7787166, DOI: 10.7326/m20-7866.Peer-Reviewed Original Research
2020
Evaluating and Deploying Covid-19 Vaccines — The Importance of Transparency, Scientific Integrity, and Public Trust
Schwartz JL. Evaluating and Deploying Covid-19 Vaccines — The Importance of Transparency, Scientific Integrity, and Public Trust. New England Journal Of Medicine 2020, 383: 1703-1705. PMID: 32966716, DOI: 10.1056/nejmp2026393.Peer-Reviewed Original ResearchEvaluation of Cancer Care After Medicaid Expansion Under the Affordable Care Act
Salazar MC, Canavan ME, Walters SL, Herrin J, Schwartz JL, Leapman M, Boffa DJ. Evaluation of Cancer Care After Medicaid Expansion Under the Affordable Care Act. JAMA Network Open 2020, 3: e2017544. PMID: 32990734, PMCID: PMC7525361, DOI: 10.1001/jamanetworkopen.2020.17544.Peer-Reviewed Original Research
2019
Association Between Food and Drug Administration Advisory Committee Recommendations and Agency Actions, 2008–2015
ZHANG AD, SCHWARTZ JL, ROSS JS. Association Between Food and Drug Administration Advisory Committee Recommendations and Agency Actions, 2008–2015. Milbank Quarterly 2019, 97: 796-819. PMID: 31304643, PMCID: PMC6739629, DOI: 10.1111/1468-0009.12403.Peer-Reviewed Original Research
2018
The Spanish Flu, Epidemics, and the Turn to Biomedical Responses.
Schwartz JL. The Spanish Flu, Epidemics, and the Turn to Biomedical Responses. American Journal Of Public Health 2018, 108: 1455-1458. PMID: 30252511, PMCID: PMC6187783, DOI: 10.2105/ajph.2018.304581.Peer-Reviewed Original ResearchConceptsTraditional public health activitiesPublic health activitiesSpanish fluVaccine developmentHealth activitiesNonpharmaceutical interventionsBiomedical interventionsInfluenza vaccine developmentEpidemic responseScientific knowledgePolitical challengesEarly 1930sFluInterventionVaccineBiomedical approachBiomedical responseCritical momentRelative priorityConsiderable enthusiasmResponseLong transitionLarge gatheringsEnthusiasm
2017
Vaccines and the Trump Administration-Reasons for Optimism Amid Uncertainty.
Schwartz JL. Vaccines and the Trump Administration-Reasons for Optimism Amid Uncertainty. American Journal Of Public Health 2017, 107: 1892-1893. PMID: 29048968, PMCID: PMC5678397, DOI: 10.2105/ajph.2017.304111.Peer-Reviewed Original ResearchUsing campaigns to improve perceptions of the value of adult vaccination in the United States: Health communication considerations and insights
Nowak GJ, Shen AK, Schwartz JL. Using campaigns to improve perceptions of the value of adult vaccination in the United States: Health communication considerations and insights. Vaccine 2017, 35: 5543-5550. PMID: 28886947, DOI: 10.1016/j.vaccine.2017.08.064.Peer-Reviewed Original ResearchConceptsAdult vaccinationAdult vaccinesSocial psychological notionHealthcare providersAdult immunization ratesPsychological notionsPsychological valueRecommended vaccinationsHealth communication literatureImmunization ratesIntegrative reviewCommunication literatureVaccinationValue perceptionsAdult HealthVaccineCommunication campaignsOverall usePerceptionPublic healthGreater supportUnited StatesHealthProvidersAssessment
2016
Fifty Years of Expert Advice — Pharmaceutical Regulation and the Legacy of the Drug Efficacy Study
Schwartz JL. Fifty Years of Expert Advice — Pharmaceutical Regulation and the Legacy of the Drug Efficacy Study. New England Journal Of Medicine 2016, 375: 2015-2017. PMID: 27959733, DOI: 10.1056/nejmp1609763.Peer-Reviewed Original ResearchState-Level Voting Patterns and Adolescent Vaccination Coverage in the United States, 2014.
Bernstein S, North A, Schwartz J, Niccolai LM. State-Level Voting Patterns and Adolescent Vaccination Coverage in the United States, 2014. American Journal Of Public Health 2016, 106: 1879-81. PMID: 27552268, PMCID: PMC5024388, DOI: 10.2105/ajph.2016.303381.Peer-Reviewed Original ResearchConceptsVoting patternsAdolescent vaccination coverageHuman papillomavirusRed statesLocal political settingPresidential election resultsVaccination coverageState-level associationsHealth care access characteristicsPolitical settingsElection resultsTetanus-containing vaccineCultural normsSocial valuesBlue statesAdolescent coverageAdolescent vaccinesMeningococcal vaccinationMultivariable modelVaccination policyPotential confoundingVaccinePolicyBoysGirls
2011
Vaccination Refusal: Ethics, Individual Rights, and the Common Good
Schwartz JL, Caplan AL. Vaccination Refusal: Ethics, Individual Rights, and the Common Good. Primary Care Clinics In Office Practice 2011, 38: 717-728. PMID: 22094142, DOI: 10.1016/j.pop.2011.07.009.Peer-Reviewed Original ResearchMeSH KeywordsEthics, MedicalHuman RightsHumansImmunization SchedulePatient CompliancePublic HealthUnited StatesVaccinesConceptsDoctor-patient relationshipEthical considerationsApparent recent increaseCommon goodHealth care providersIndividual rightsPublic healthVaccination recommendationsVaccination scheduleVaccination programCare providersVaccine refusalPossible responsesOutright resistanceEthicsParental attitudesHealthRightsPatientsRefusalVaccinePhysiciansGoods
2007
Lessons from the Failure of Human Papillomavirus Vaccine State Requirements
Schwartz JL, Caplan AL, Faden RR, Sugarman J. Lessons from the Failure of Human Papillomavirus Vaccine State Requirements. Clinical Pharmacology & Therapeutics 2007, 82: 760-763. PMID: 17971822, DOI: 10.1038/sj.clpt.6100397.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultChildDrug CostsDrug IndustryFemaleHealth Services AccessibilityHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18HumansLobbyingMandatory ProgramsMass VaccinationMichiganPapillomavirus InfectionsPapillomavirus VaccinesParentsPersonal AutonomyPoliticsPublic PolicySchoolsSexually Transmitted Diseases, ViralState GovernmentTexasTumor Virus InfectionsUnited StatesUterine Cervical NeoplasmsConceptsHuman papillomavirusCervical cancerCervical cancer prevention effortsHPV vaccination programCancer prevention effortsPublic health issueHPV vaccinationGenital wartsVaccination programCancer preventionEffective vaccineGreater prevalenceVaccinePrevention effortsHealth issuesConservative groupGlobal healthVaccinationCancerLicensurePapillomavirusMortalityPrevalenceSubtypesWarts